Literature DB >> 11871802

The future of polio eradication.

H F Hull1.   

Abstract

As the global polio eradication initiative comes ever closer to its goal of terminating of all wild poliovirus transmission, significant challenges remain. Wild poliovirus transmission must be terminated in countries where low-level transmission persists, in large reservoir countries with high population density, and in conflict countries. Eradication can be achieved in these countries with determined and persistent effort, assuming that sufficient resources are mobilised. High quality surveillance needs to be implemented in the remaining polio endemic countries, especially in Africa. Surveillance is necessary in all countries until eradication is certified. A strategy for stopping immunisation after eradication is yet to be defined. A definition of this strategy would address the emergence of feral polioviruses, chronic vaccine virus infection in immunodeficient persons, and containment of laboratory strains. Until immunisation is stopped, high-population immunity should be maintained through uniformly high immunisation coverage with potent vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11871802     DOI: 10.1016/S1473-3099(01)00143-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  2 in total

1.  Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine.

Authors:  E A Cherkasova; M L Yakovenko; G V Rezapkin; E A Korotkova; O E Ivanova; T P Eremeeva; L I Krasnoproshina; N I Romanenkova; N R Rozaeva; L Sirota; V I Agol; K M Chumakov
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Strategies for Improving Polio Surveillance Performance in the Security-Challenged Nigerian States of Adamawa, Borno, and Yobe During 2009-2014.

Authors:  Abdullahi Walla Hamisu; Ticha Muluh Johnson; Kehinde Craig; Pascal Mkanda; Richard Banda; Sisay G Tegegne; Ajiboye Oyetunji; Nuhu Ningi; Said M Mohammed; Mohammed Isa Adamu; Khalid Abdulrahim; Peter Nsubuga; Rui G Vaz; Ado J G Muhammed
Journal:  J Infect Dis       Date:  2015-12-10       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.